This review attempts to discuss the role of positron emission tomography (PET) imaging for staging, treatment response and follow-up of patients with lymphoma. The pitfalls and impact of PET imaging on the clinical management are also addressed.

Author

Conor D Collins

Contact Details

Corresponding address:
St Vincent's University Hospital,
Dublin 4,
Ireland

Reference

ICIS Cancer Imaging Volume 6 Special Issue A
DOI: 10.1102/1470-7330.2006.9013

Date Posted

31 October 2006

Print PDF

Size

274.30 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	4 seconds
64 Kb/s (ISDN):	34 seconds
33.3 Kb/s (Typical Modem):	1 minute 5 seconds

Screen PDF

Size

341.58 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 second
ADSL 512Kb/s (Broadband):	5 seconds
64 Kb/s (ISDN):	42 seconds
33.3 Kb/s (Typical Modem):	1 minute 22 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 66356, London, E14 1GW. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.